Similarly, neutralizing IL-1β activity through the use of the IL-1 receptor antagonist is protective in multiple systems, including arthritis, diabetes, metabolic syndrome, psoriasis, periodic fevers, and gout among others (62). This evidence concerns the gene IL1B and psoriasis.